Navigation Links
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
Date:5/28/2008

rtunity for shareholders."

"We were attracted by the immediate value and the potential future value this transaction creates for Sonus and OncoGenex shareholders," said Mr. Cormack. "Our companies are built around very similar approaches to developing oncology products that provide better therapeutic alternatives for cancer patients. This transaction provides an exciting opportunity for the stockholders of both companies to realize the full value of each company's assets."

The combined company will have a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. In addition to OGX-011, the pipeline includes two product candidates in Phase 1, and one additional product candidate that the company anticipates will move into Phase 1 clinical development within 18 months. Details on the specific products follow:

- OGX-011, also known as custirsen sodium, inhibits the production of

clusterin, a protein that is associated with treatment resistance in

a number of solid tumors, including prostate, breast, non-small cell

lung, ovarian, and bladder cancers. It has potential applicability as

a therapeutic in a broad number of cancers at different stages and

can potentially be used in combination with a variety of commonly

used cancer treatments, including chemotherapy, radiation therapy,

and hormone ablation therapy. Preliminary data in a Phase 2 clinical

trial evaluating OGX-011 in combination with second-line chemotherapy

in patients with hormone refractory prostate cancer has shown that

retreatment with docetaxel in combination with OGX-011 may reverse

docetaxel resistance and improve survival. OGX-011 is planned to

enter randomized clinical trials in patients with hormone refractory

prostate cancer that will support a N
'/>"/>

SOURCE OncoGenex Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
2. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
3. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
4. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
5. VentiRx Pharmaceuticals Appoints Dr. Elliott Grossbard to Board of Directors
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
8. MAP Pharmaceuticals to Present at the 2008 Citi Investment Research Global Healthcare Conference
9. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
10. Transdel Pharmaceuticals Closes $4 Million Financing
11. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Sales Horizons, a leader in sales training, ... course – Mastering the Complex Sale – ... from proven sales training programs used by thousands of ... online sales training course is available to every salesperson ... with customers, like technical support, engineers, clinical support, and ...
(Date:7/30/2014)... 30, 2014 W. R. Grace ... of the REVELERIS® Prep purification system , ... chromatographers, and other researchers to perform both flash ... unit. , With the REVELERIS® Prep purification system, ... chromatography modes with a simple touch of the ...
(Date:7/30/2014)... CHICAGO , July 30, 2014  The Chicago ... the American Academy of Dermatology (Academy) in an effort ... the Chicago Bears will host free SPOT me™ skin ... August 2 at Soldier Field. SPOT me™ is ... men, about the dangers and risks of skin cancer, ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Selexis ... for biologic drug discovery and mammalian cell line development, ... CHO-Mplus Libraries ™ will be presented at the 10th ... being held, September 8 – 10, 2014 at the ... , The following abstract will be presented during ...
Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Grace Launches New REVELERIS® Prep Purification System 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... 28 /PRNewswire-FirstCall/ - Oncothyreon Inc. (the,"Company") (Nasdaq: ... development of innovative therapeutic products for the treatment ... clinical development plans,and corporate objectives for 2008. Oncothyreon ... molecules with the potential to,improve the lives and ...
... PARIS, January 28 Sanofi-aventis announced,today that ... approved for marketing in Japan by the ... prevention of venous thromboembolism (VTE) in patients,undergoing ... as total hip,replacement, total knee replacement and ...
... Calif., Jan. 25 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... the Wachovia Healthcare Conference on Wednesday, January 30, ... a live webcast of the,presentation at:, ... log on 15 minutes early in order to,register ...
Cached Biology Technology:Oncothyreon highlights corporate and clinical objectives for 2008 2Oncothyreon highlights corporate and clinical objectives for 2008 3Oncothyreon highlights corporate and clinical objectives for 2008 4Oncothyreon highlights corporate and clinical objectives for 2008 5Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5
(Date:7/31/2014)... researchers have completed a 20-year study that looks ... at different times of the year. It finds ... time frame has no measurable negative consequences for ... benefits. , The study was conducted by Gene ... Station fire chief, and Joseph Craine, research assistant ...
(Date:7/31/2014)... Do people make a rational choice to be liberal ... Is it a matter of genetics?, Two political scientists ... Rice University say that neither conscious decision-making nor parental ... others lean right. , A growing body of evidence ... the core of political differences, the researchers say in ...
(Date:7/31/2014)... that the U.S. surgeon general issued a 101-page report ... State University published a paper breaking new ground on ... responds when exposed to ultraviolet (UV) light. , ... the UV rays found in sunlight. This damage can ... diseases. , "Our paper advances foundational knowledge about ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3Scientists find growing consensus: Political attitudes derive from body and mind 2New paper describes how DNA avoids damage from UV light 2New paper describes how DNA avoids damage from UV light 3
... furrow rainwater-harvesting (RFRH) systems with mulches were first researched ... to improve water availability and to increase crop production. ... zones, and bare or mulched furrows serve as planting ... being promoted in many parts of the world as ...
... MENOMONIE, WIAs consumer demand for convenient, nutritious foods ... popular. Food producers are looking to science to discover ... these "minimally processed" products. A potential solution to vegetables, ... irradiation, the latest ionizing irradiation technology currently in use ...
... University, Sandia National Laboratories, and the University of California, ... to allow doctors to detect real-time chemical changes in ... an extended period of time. "We,ve loaded the ... be used to detect specific molecules or pH levels," ...
Cached Biology News:Improved rainwater harvesting system promising 2Asparagus benefits from X-ray treatment 2Microneedle sensors may allow real-time monitoring of body chemistry 2
PFM8 Antibody...
Rabbit polyclonal to NCoR2, prediluted ( Abpromise for all tested applications). entrezGeneID: 9612 SwissProtID: Q9Y618...
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....
Biology Products: